U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07551778) titled 'Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors' on April 10.
Brief Summary: This is a prospective, open-label, exploratory clinical study to evaluate the safety and preliminary efficacy of allogeneic natural killer (NK) cell injection combined with standard maintenance therapy in patients with locally advanced or metastatic solid tumors. The study consists of three cohorts: Cohort 1 (advanced non-squamous NSCLC with NK cells + PD-(L)1 inhibitor + pemetrexed), Cohort 2 (advanced colorectal adenocarcinoma with NK cells + cetuximab/bevacizumab + capecitabine), and Cohort 3 (lymphodeple...